Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc(TM) System

Stock Information for Accelerate Diagnostics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Accelerate Diagnostics Inc.

Accelerate Diagnostics Reports Second Quarter 2024 Financial Results
Accelerate Diagnostics Announces a Successful Completion of its WAVE(TM) Pre-Clinical Trial
Accelerate Diagnostics Scheduled Call to Review 2024 Second Quarter Results
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.